SCHEMBL25137079

SCHEMBL25137079

COCc1nc(Cl)c(F)c2nc(Cl)nc(Cl)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25136947 0.77 — —
SCHEMBL26932615 0.75 CYP1A2 (0.40) —
SCHEMBL30427115 0.74 ALDH1A1 (0.32) —
SCHEMBL24663882 0.74 ALDH1A1 (0.32) —
SCHEMBL30798175 0.74 KRAS (0.36) —
SCHEMBL25136998 0.74 TSHR (0.32) —
SCHEMBL31196801 0.74 TSHR (0.32) —
SCHEMBL24985595 0.73 CYP1A2 (0.41) —
SCHEMBL28906444 0.72 — —
SCHEMBL25137001 0.72 PGK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024051852-A1 PYRIMIDINE-CONTAINING POLYCYCLIC BIOLOGICAL INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海翰森生物医药科技有限公司 2024-03-14 — — WO disclosed
WO-2023061463-A1 NOVEL PYRIMIDOPYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 广东东阳光药业有限公司 2023-04-20 — — WO disclosed
Send feedback